nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—Night sweats—Zoledronate—Paget's disease of bone	0.0157	0.0157	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Alendronate—Paget's disease of bone	0.0135	0.0135	CcSEcCtD
Levomilnacipran—Endocrine disorder—Risedronate—Paget's disease of bone	0.0118	0.0118	CcSEcCtD
Levomilnacipran—Contusion—Risedronate—Paget's disease of bone	0.0112	0.0112	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Risedronate—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Levomilnacipran—Hypercholesterolaemia—Risedronate—Paget's disease of bone	0.0103	0.0103	CcSEcCtD
Levomilnacipran—Proteinuria—Zoledronate—Paget's disease of bone	0.00966	0.00966	CcSEcCtD
Levomilnacipran—Cystitis noninfective—Risedronate—Paget's disease of bone	0.00955	0.00955	CcSEcCtD
Levomilnacipran—Protein urine present—Zoledronate—Paget's disease of bone	0.00952	0.00952	CcSEcCtD
Levomilnacipran—Cystitis—Risedronate—Paget's disease of bone	0.00944	0.00944	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Zoledronate—Paget's disease of bone	0.0094	0.0094	CcSEcCtD
Levomilnacipran—Dyspepsia—Tiludronate—Paget's disease of bone	0.00937	0.00937	CcSEcCtD
Levomilnacipran—Dry eye—Risedronate—Paget's disease of bone	0.00903	0.00903	CcSEcCtD
Levomilnacipran—Bladder pain—Risedronate—Paget's disease of bone	0.00884	0.00884	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00871	0.00871	CcSEcCtD
Levomilnacipran—Abdominal pain—Tiludronate—Paget's disease of bone	0.00842	0.00842	CcSEcCtD
Levomilnacipran—Dry skin—Alendronate—Paget's disease of bone	0.0081	0.0081	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.00793	0.00793	CcSEcCtD
Levomilnacipran—Abdominal distension—Alendronate—Paget's disease of bone	0.00769	0.00769	CcSEcCtD
Levomilnacipran—Asthenia—Tiludronate—Paget's disease of bone	0.00764	0.00764	CcSEcCtD
Levomilnacipran—Renal failure acute—Pamidronate—Paget's disease of bone	0.0073	0.0073	CcSEcCtD
Levomilnacipran—Diarrhoea—Tiludronate—Paget's disease of bone	0.00729	0.00729	CcSEcCtD
Levomilnacipran—Hallucination—Etidronic acid—Paget's disease of bone	0.00714	0.00714	CcSEcCtD
Levomilnacipran—Dizziness—Tiludronate—Paget's disease of bone	0.00704	0.00704	CcSEcCtD
Levomilnacipran—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00679	0.00679	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.00676	0.00676	CcSEcCtD
Levomilnacipran—Renal failure acute—Zoledronate—Paget's disease of bone	0.00667	0.00667	CcSEcCtD
Levomilnacipran—Headache—Tiludronate—Paget's disease of bone	0.00667	0.00667	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Risedronate—Paget's disease of bone	0.00655	0.00655	CcSEcCtD
Levomilnacipran—Thirst—Zoledronate—Paget's disease of bone	0.00647	0.00647	CcSEcCtD
Levomilnacipran—Breast disorder—Risedronate—Paget's disease of bone	0.00641	0.00641	CcSEcCtD
Levomilnacipran—Nausea—Tiludronate—Paget's disease of bone	0.00633	0.00633	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.00623	0.00623	CcSEcCtD
Levomilnacipran—Abdominal distension—Risedronate—Paget's disease of bone	0.00617	0.00617	CcSEcCtD
Levomilnacipran—Flatulence—Etidronic acid—Paget's disease of bone	0.00616	0.00616	CcSEcCtD
Levomilnacipran—Oedema peripheral—Alendronate—Paget's disease of bone	0.00603	0.00603	CcSEcCtD
Levomilnacipran—Angina pectoris—Risedronate—Paget's disease of bone	0.00597	0.00597	CcSEcCtD
Levomilnacipran—Erythema multiforme—Alendronate—Paget's disease of bone	0.00578	0.00578	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.0057	0.0057	CcSEcCtD
Levomilnacipran—Leukopenia—Etidronic acid—Paget's disease of bone	0.00559	0.00559	CcSEcCtD
Levomilnacipran—Neutropenia—Pamidronate—Paget's disease of bone	0.00545	0.00545	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00542	0.00542	CcSEcCtD
Levomilnacipran—Abdominal distension—Zoledronate—Paget's disease of bone	0.00536	0.00536	CcSEcCtD
Levomilnacipran—Urinary tract infection—Risedronate—Paget's disease of bone	0.00531	0.00531	CcSEcCtD
Levomilnacipran—Flatulence—Alendronate—Paget's disease of bone	0.00525	0.00525	CcSEcCtD
Levomilnacipran—Dysgeusia—Alendronate—Paget's disease of bone	0.00521	0.00521	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00517	0.00517	CcSEcCtD
Levomilnacipran—Infection—Etidronic acid—Paget's disease of bone	0.00507	0.00507	CcSEcCtD
Levomilnacipran—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00505	0.00505	CcSEcCtD
Levomilnacipran—Neutropenia—Zoledronate—Paget's disease of bone	0.00498	0.00498	CcSEcCtD
Levomilnacipran—Haematuria—Pamidronate—Paget's disease of bone	0.00496	0.00496	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00495	0.00495	CcSEcCtD
Levomilnacipran—Pollakiuria—Zoledronate—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00485	0.00485	CcSEcCtD
Levomilnacipran—Oedema peripheral—Risedronate—Paget's disease of bone	0.00483	0.00483	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00482	0.00482	CcSEcCtD
Levomilnacipran—Weight decreased—Zoledronate—Paget's disease of bone	0.00482	0.00482	CcSEcCtD
Levomilnacipran—Urethral disorder—Risedronate—Paget's disease of bone	0.00481	0.00481	CcSEcCtD
Levomilnacipran—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00461	0.00461	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00461	0.00461	CcSEcCtD
Levomilnacipran—Eye disorder—Risedronate—Paget's disease of bone	0.00459	0.00459	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00458	0.00458	CcSEcCtD
Levomilnacipran—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00458	0.00458	CcSEcCtD
Levomilnacipran—Urethral disorder—Pamidronate—Paget's disease of bone	0.00457	0.00457	CcSEcCtD
Levomilnacipran—Cardiac disorder—Risedronate—Paget's disease of bone	0.00455	0.00455	CcSEcCtD
Levomilnacipran—Chest pain—Alendronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Levomilnacipran—Haematuria—Zoledronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Levomilnacipran—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00449	0.00449	CcSEcCtD
Levomilnacipran—Angiopathy—Risedronate—Paget's disease of bone	0.00445	0.00445	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Levomilnacipran—Constipation—Etidronic acid—Paget's disease of bone	0.00436	0.00436	CcSEcCtD
Levomilnacipran—Eye disorder—Pamidronate—Paget's disease of bone	0.00436	0.00436	CcSEcCtD
Levomilnacipran—Flushing—Pamidronate—Paget's disease of bone	0.00433	0.00433	CcSEcCtD
Levomilnacipran—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00433	0.00433	CcSEcCtD
Levomilnacipran—Infection—Alendronate—Paget's disease of bone	0.00432	0.00432	CcSEcCtD
Levomilnacipran—Mental disorder—Risedronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Levomilnacipran—Malnutrition—Risedronate—Paget's disease of bone	0.00427	0.00427	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00424	0.00424	CcSEcCtD
Levomilnacipran—Angiopathy—Pamidronate—Paget's disease of bone	0.00423	0.00423	CcSEcCtD
Levomilnacipran—Flatulence—Risedronate—Paget's disease of bone	0.00421	0.00421	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00421	0.00421	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.0042	0.0042	CcSEcCtD
Levomilnacipran—Oedema peripheral—Zoledronate—Paget's disease of bone	0.0042	0.0042	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00419	0.00419	CcSEcCtD
Levomilnacipran—Chills—Pamidronate—Paget's disease of bone	0.00419	0.00419	CcSEcCtD
Levomilnacipran—Urethral disorder—Zoledronate—Paget's disease of bone	0.00418	0.00418	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00417	0.00417	CcSEcCtD
Levomilnacipran—Malnutrition—Pamidronate—Paget's disease of bone	0.00406	0.00406	CcSEcCtD
Levomilnacipran—Urticaria—Etidronic acid—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Levomilnacipran—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00403	0.00403	CcSEcCtD
Levomilnacipran—Tension—Pamidronate—Paget's disease of bone	0.00399	0.00399	CcSEcCtD
Levomilnacipran—Eye disorder—Zoledronate—Paget's disease of bone	0.00398	0.00398	CcSEcCtD
Levomilnacipran—Dysgeusia—Pamidronate—Paget's disease of bone	0.00398	0.00398	CcSEcCtD
Levomilnacipran—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00396	0.00396	CcSEcCtD
Levomilnacipran—Flushing—Zoledronate—Paget's disease of bone	0.00396	0.00396	CcSEcCtD
Levomilnacipran—Angiopathy—Zoledronate—Paget's disease of bone	0.00387	0.00387	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00384	0.00384	CcSEcCtD
Levomilnacipran—Syncope—Risedronate—Paget's disease of bone	0.00383	0.00383	CcSEcCtD
Levomilnacipran—Dyspepsia—Alendronate—Paget's disease of bone	0.00383	0.00383	CcSEcCtD
Levomilnacipran—Chills—Zoledronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Levomilnacipran—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Levomilnacipran—Loss of consciousness—Risedronate—Paget's disease of bone	0.00375	0.00375	CcSEcCtD
Levomilnacipran—Mental disorder—Zoledronate—Paget's disease of bone	0.00373	0.00373	CcSEcCtD
Levomilnacipran—Agitation—Pamidronate—Paget's disease of bone	0.00373	0.00373	CcSEcCtD
Levomilnacipran—Constipation—Alendronate—Paget's disease of bone	0.00372	0.00372	CcSEcCtD
Levomilnacipran—Malnutrition—Zoledronate—Paget's disease of bone	0.00371	0.00371	CcSEcCtD
Levomilnacipran—Hypertension—Risedronate—Paget's disease of bone	0.00369	0.00369	CcSEcCtD
Levomilnacipran—Syncope—Pamidronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Levomilnacipran—Chest pain—Risedronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Levomilnacipran—Leukopenia—Pamidronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Levomilnacipran—Dysgeusia—Zoledronate—Paget's disease of bone	0.00363	0.00363	CcSEcCtD
Levomilnacipran—Anxiety—Risedronate—Paget's disease of bone	0.00362	0.00362	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Levomilnacipran—Pruritus—Etidronic acid—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Levomilnacipran—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00357	0.00357	CcSEcCtD
Levomilnacipran—Dry mouth—Risedronate—Paget's disease of bone	0.00356	0.00356	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00355	0.00355	CcSEcCtD
Levomilnacipran—Convulsion—Pamidronate—Paget's disease of bone	0.00352	0.00352	CcSEcCtD
Levomilnacipran—Hypertension—Pamidronate—Paget's disease of bone	0.00351	0.00351	CcSEcCtD
Levomilnacipran—Vision blurred—Zoledronate—Paget's disease of bone	0.0035	0.0035	CcSEcCtD
Levomilnacipran—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00349	0.00349	CcSEcCtD
Levomilnacipran—Tremor—Zoledronate—Paget's disease of bone	0.00348	0.00348	CcSEcCtD
Levomilnacipran—Infection—Risedronate—Paget's disease of bone	0.00346	0.00346	CcSEcCtD
Levomilnacipran—Urticaria—Alendronate—Paget's disease of bone	0.00345	0.00345	CcSEcCtD
Levomilnacipran—Anxiety—Pamidronate—Paget's disease of bone	0.00345	0.00345	CcSEcCtD
Levomilnacipran—Abdominal pain—Alendronate—Paget's disease of bone	0.00344	0.00344	CcSEcCtD
Levomilnacipran—Body temperature increased—Alendronate—Paget's disease of bone	0.00344	0.00344	CcSEcCtD
Levomilnacipran—Shock—Risedronate—Paget's disease of bone	0.00343	0.00343	CcSEcCtD
Levomilnacipran—Nervous system disorder—Risedronate—Paget's disease of bone	0.00342	0.00342	CcSEcCtD
Levomilnacipran—Agitation—Zoledronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Levomilnacipran—Skin disorder—Risedronate—Paget's disease of bone	0.00339	0.00339	CcSEcCtD
Levomilnacipran—Syncope—Zoledronate—Paget's disease of bone	0.00333	0.00333	CcSEcCtD
Levomilnacipran—Leukopenia—Zoledronate—Paget's disease of bone	0.00332	0.00332	CcSEcCtD
Levomilnacipran—Infection—Pamidronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Levomilnacipran—Palpitations—Zoledronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Levomilnacipran—Shock—Pamidronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Levomilnacipran—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Levomilnacipran—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00325	0.00325	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00325	0.00325	CcSEcCtD
Levomilnacipran—Vomiting—Etidronic acid—Paget's disease of bone	0.00324	0.00324	CcSEcCtD
Levomilnacipran—Tachycardia—Pamidronate—Paget's disease of bone	0.00323	0.00323	CcSEcCtD
Levomilnacipran—Rash—Etidronic acid—Paget's disease of bone	0.00322	0.00322	CcSEcCtD
Levomilnacipran—Convulsion—Zoledronate—Paget's disease of bone	0.00321	0.00321	CcSEcCtD
Levomilnacipran—Dermatitis—Etidronic acid—Paget's disease of bone	0.00321	0.00321	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.0032	0.0032	CcSEcCtD
Levomilnacipran—Hypertension—Zoledronate—Paget's disease of bone	0.0032	0.0032	CcSEcCtD
Levomilnacipran—Hypersensitivity—Alendronate—Paget's disease of bone	0.0032	0.0032	CcSEcCtD
Levomilnacipran—Headache—Etidronic acid—Paget's disease of bone	0.00319	0.00319	CcSEcCtD
Levomilnacipran—Anorexia—Pamidronate—Paget's disease of bone	0.00316	0.00316	CcSEcCtD
Levomilnacipran—Chest pain—Zoledronate—Paget's disease of bone	0.00316	0.00316	CcSEcCtD
Levomilnacipran—Insomnia—Risedronate—Paget's disease of bone	0.00315	0.00315	CcSEcCtD
Levomilnacipran—Anxiety—Zoledronate—Paget's disease of bone	0.00315	0.00315	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00314	0.00314	CcSEcCtD
Levomilnacipran—Paraesthesia—Risedronate—Paget's disease of bone	0.00313	0.00313	CcSEcCtD
Levomilnacipran—Asthenia—Alendronate—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Levomilnacipran—Dyspnoea—Risedronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Levomilnacipran—Hypotension—Pamidronate—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Levomilnacipran—Dry mouth—Zoledronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Levomilnacipran—Pruritus—Alendronate—Paget's disease of bone	0.00307	0.00307	CcSEcCtD
Levomilnacipran—Dyspepsia—Risedronate—Paget's disease of bone	0.00307	0.00307	CcSEcCtD
Levomilnacipran—Nausea—Etidronic acid—Paget's disease of bone	0.00303	0.00303	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Levomilnacipran—Infection—Zoledronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Levomilnacipran—Fatigue—Risedronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Levomilnacipran—Insomnia—Pamidronate—Paget's disease of bone	0.003	0.003	CcSEcCtD
Levomilnacipran—Constipation—Risedronate—Paget's disease of bone	0.00298	0.00298	CcSEcCtD
Levomilnacipran—Shock—Zoledronate—Paget's disease of bone	0.00298	0.00298	CcSEcCtD
Levomilnacipran—Paraesthesia—Pamidronate—Paget's disease of bone	0.00298	0.00298	CcSEcCtD
Levomilnacipran—Diarrhoea—Alendronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Levomilnacipran—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Levomilnacipran—Dyspnoea—Pamidronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Levomilnacipran—Tachycardia—Zoledronate—Paget's disease of bone	0.00295	0.00295	CcSEcCtD
Levomilnacipran—Somnolence—Pamidronate—Paget's disease of bone	0.00295	0.00295	CcSEcCtD
Levomilnacipran—Skin disorder—Zoledronate—Paget's disease of bone	0.00294	0.00294	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00293	0.00293	CcSEcCtD
Levomilnacipran—Dyspepsia—Pamidronate—Paget's disease of bone	0.00292	0.00292	CcSEcCtD
Levomilnacipran—Anorexia—Zoledronate—Paget's disease of bone	0.00289	0.00289	CcSEcCtD
Levomilnacipran—Decreased appetite—Pamidronate—Paget's disease of bone	0.00288	0.00288	CcSEcCtD
Levomilnacipran—Dizziness—Alendronate—Paget's disease of bone	0.00287	0.00287	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00286	0.00286	CcSEcCtD
Levomilnacipran—Fatigue—Pamidronate—Paget's disease of bone	0.00286	0.00286	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00285	0.00285	CcSEcCtD
Levomilnacipran—Constipation—Pamidronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Levomilnacipran—Hypotension—Zoledronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Levomilnacipran—Urticaria—Risedronate—Paget's disease of bone	0.00277	0.00277	CcSEcCtD
Levomilnacipran—Vomiting—Alendronate—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Levomilnacipran—Abdominal pain—Risedronate—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Levomilnacipran—Body temperature increased—Risedronate—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Levomilnacipran—Rash—Alendronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Levomilnacipran—Insomnia—Zoledronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Levomilnacipran—Dermatitis—Alendronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Levomilnacipran—Headache—Alendronate—Paget's disease of bone	0.00272	0.00272	CcSEcCtD
Levomilnacipran—Paraesthesia—Zoledronate—Paget's disease of bone	0.00272	0.00272	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Levomilnacipran—Dyspnoea—Zoledronate—Paget's disease of bone	0.0027	0.0027	CcSEcCtD
Levomilnacipran—Somnolence—Zoledronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Levomilnacipran—Dyspepsia—Zoledronate—Paget's disease of bone	0.00267	0.00267	CcSEcCtD
Levomilnacipran—Decreased appetite—Zoledronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Levomilnacipran—Abdominal pain—Pamidronate—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Levomilnacipran—Body temperature increased—Pamidronate—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00261	0.00261	CcSEcCtD
Levomilnacipran—Fatigue—Zoledronate—Paget's disease of bone	0.00261	0.00261	CcSEcCtD
Levomilnacipran—Constipation—Zoledronate—Paget's disease of bone	0.00259	0.00259	CcSEcCtD
Levomilnacipran—Nausea—Alendronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Levomilnacipran—Hypersensitivity—Risedronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Levomilnacipran—Asthenia—Risedronate—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Levomilnacipran—Pruritus—Risedronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Levomilnacipran—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Levomilnacipran—Urticaria—Zoledronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Levomilnacipran—Abdominal pain—Zoledronate—Paget's disease of bone	0.00239	0.00239	CcSEcCtD
Levomilnacipran—Body temperature increased—Zoledronate—Paget's disease of bone	0.00239	0.00239	CcSEcCtD
Levomilnacipran—Diarrhoea—Risedronate—Paget's disease of bone	0.00239	0.00239	CcSEcCtD
Levomilnacipran—Asthenia—Pamidronate—Paget's disease of bone	0.00238	0.00238	CcSEcCtD
Levomilnacipran—Pruritus—Pamidronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Levomilnacipran—Dizziness—Risedronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Levomilnacipran—Diarrhoea—Pamidronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Levomilnacipran—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00223	0.00223	CcSEcCtD
Levomilnacipran—Vomiting—Risedronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Levomilnacipran—Rash—Risedronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Levomilnacipran—Dermatitis—Risedronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Levomilnacipran—Dizziness—Pamidronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Levomilnacipran—Headache—Risedronate—Paget's disease of bone	0.00218	0.00218	CcSEcCtD
Levomilnacipran—Asthenia—Zoledronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Levomilnacipran—Pruritus—Zoledronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Levomilnacipran—Vomiting—Pamidronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Levomilnacipran—Rash—Pamidronate—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Levomilnacipran—Dermatitis—Pamidronate—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Levomilnacipran—Headache—Pamidronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Levomilnacipran—Diarrhoea—Zoledronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Levomilnacipran—Nausea—Risedronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Levomilnacipran—Dizziness—Zoledronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Levomilnacipran—Nausea—Pamidronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Levomilnacipran—Vomiting—Zoledronate—Paget's disease of bone	0.00193	0.00193	CcSEcCtD
Levomilnacipran—Rash—Zoledronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Levomilnacipran—Dermatitis—Zoledronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Levomilnacipran—Headache—Zoledronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Levomilnacipran—Nausea—Zoledronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
